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Limited responsiveness to inflammatory cytokines is
a feature of adult hematopoietic stem cells and con-
tributes to the relative quiescence and durability of
the stem cell population in vivo. Here we report that
the executioner Caspase, Caspase-3, unexpectedly
participates in that process. Mice deficient in
Caspase-3 had increased numbers of immuno-
phenotypic long-term repopulating stem cells in
association with multiple functional changes, most
prominently cell cycling. Though these changes
were cell autonomous, they reflected altered activa-
tion by exogenous signals. Caspase-3/ cells ex-
hibited cell type-specific changes in phosphorylated
members of the Ras-Raf-MEK-ERK pathway in res-
ponse to specific cytokines, while notably, members
of other pathways, such as pSTAT3, pSTAT5, pAKT,
pp38 MAPK, pSmad2, and pSmad3, were unaf-
fected. Caspase-3 contributes to stem cell quies-
cence, dampening specific signaling events and
thereby cell responsiveness to microenvironmental
stimuli.
INTRODUCTION
In organs with a high turnover of cells, stem cells must be strictly
regulated to ensure the balance between the preservation of the
stem cell pool and differentiation to continuously replace mature
cells lost due to injury, disease, or wear. Continuous and precisely
controlled elimination of cells by programmed cells death (apo-
ptosis) prevents excess accumulation of normal cells and enables
culling of defective cells. The balance between self-renewal, dif-
ferentiation, and apoptosis at the stem cell level can affect tissue
function and is critical for the survival of the organism. We are in-
terested in how these processes are integrated through a limited
number of molecular events in these generally quiescent cell584 Cell Stem Cell 2, 584–594, June 2008 ª2008 Elsevier Inc.types. We focused on Caspase proteases as a group of enzymes
capable of modulating multiple protein targets.
Caspase-3 was selected because of its central role in the ap-
optotic process as an executioner protease and because several
lines of evidence implicate it in nonapoptotic functions. For
example, altering the expression level or enzymatic activity of
Caspase-3 in vitro has implicated Caspase-3 in specific stages
of erythroid and megakaryocytic differentiation (Carlile et al.,
2004; de Botton et al., 2002; Zermati et al., 2001). Intracellular
Caspase-3 activation has been observed during differentiation
in the absence of apparent apoptotic induction in neural and he-
matopoietic cells (Fernando et al., 2005; de Botton et al., 2002).
In addition, Caspase-3 has a cell type-dependent effect on cell
proliferation. Though splenic B cells showed hyperproliferation
in absence of Caspase-3 (Woo et al., 2003), bone marrow stro-
mal stem cells exhibited reduced cycling activity (Miura et al.,
2004). Yet, Caspase-3 deficiency did not alter the frequency of
apoptosis in either of the cell types.
We report here that alteration in Caspase-3 expression per-
turbs the homeostasis of primitive hematopoietic cells. Cas-
pase-3-deficient stem cells displayed accelerated proliferation
and retarded differentiation. At the molecular level, Caspase-3
altered the sensitivity of primary hematopoietic cells to cytokine
stimulation through modulation of specific signaling pathways.
The data indicate a novel role for Caspase-3 as a governor,
downmodulating stem cell responsiveness to environmental sig-
nals, and point to proteases as central to the processes regulat-
ing the stem cell compartment.
RESULTS
The Composition of the Primitive Hematopoietic
Bone Marrow Compartment Is Affected
by Caspase-3 Expression
To establish the potential for Caspase-3 to play a regulatory role
in primitive hematopoietic cell function, we assayed wild-type
populations of blood cells for the expression of Caspase-3 mes-
sage and protein. We detected high levels of Caspase-3 mRNA
in sorted primitive bone marrow compartments defined as
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Caspase-3 Limits HSC Cytokine ResponseFigure 1. Caspase-3 Is Expressed in Primitive BM Cells and Affects the Frequency of Cell Subsets
(A) Expression of Caspase-3 mRNA in sorted bone marrow stem (LK+S+) and progenitor (LK+S) cell-containing populations as determined by quantitative
RT-PCR. Hprt-1 was used as a housekeeping control. Representative plots from three independent experiments are shown.
(B) Intracellular staining for full-length Caspase-3 demonstrates high levels of Caspase-3 protein expression in HSC and HPC compartment. Bone marrow from
Caspase-3 KO mice were used as controls. Representative plots from three independent experiments are shown.
(C) The HSC-containingpopulationascharacterized by the immunophenotype (LK+S+) is significantlyelevated inCaspase-3KO micewith striking accumulation of the
LT-HSC (LK+S+CD34lowFlk2low). The frequency of progenitor cells (LK+S) is slightly reduced in Caspase-3 deficient mice with a significant reduction of the common
myeloid progenitor-containing population. FACS plots are gated on lineage-negative bone marrow cells, and numbers indicate the percentage of subpopulations
within the total nucleated bone marrow cells. No significantdifferences between the genotype were detected for the common lymphoid progenitor (CLP), granulocytic
macrophages progenitor (GMP), and megakaryocytic erytroid progenitor (MEP) populations. Values are mean ± SD xp < 0.05; *p < 0.001; n = 7.lineage negative, cKit positive, and Sca-1 positive population
(LK+S+), enriched for stem cells, and also in the more mature pro-
genitor population, defined as lineage negative, cKit positive,and Sca-1 negative (LK+S) (Figure 1A). Caspase-3 protein
was also detectable in the LK+S+ and LK+S populations of
mouse bone marrow assayed by flow cytometry (Figure 1B).Cell Stem Cell 2, 584–594, June 2008 ª2008 Elsevier Inc. 585
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Caspase-3 Limits HSC Cytokine ResponseTo analyze whether Caspase-3 affected hematopoiesis
in vivo, we used mice engineered to be deficient for Caspase-3
(Woo et al., 2003). Analysis of peripheral blood cell counts re-
vealed unchanged levels of red blood cells and platelets, and
a slight but not significant decrease in the total white blood
count. Differential analysis of white blood cells showed a signifi-
cant reduction in B and T lymphocytes with no significant reduc-
tion in myeloid cells in Caspase-3/ (KO) animals (see Figure S1
available online). KO mice were smaller in body size than were
their wild-type littermates, as also noted previously by others
(Kuida et al., 1996; Woo et al., 1998; Miura et al., 2004). The total
bone marrow cellularity per femur and the normalized, relative
cell number per gram of body weight were both significantly re-
duced in KO mice (Figure S2).
The effect of Caspase-3 deficiency on primitive subpopulations
in the bone marrow was then examined. We observed a doubling
in the frequency of LK+S+ cells in KOs, compared with their wild-
type littermates. When the LK+S+ population was further subfrac-
tionated into the long-term HSC-containing population
LK+S+CD34lowFlk2low, the short-term repopulating HSC popula-
tion LK+S+CD34+Flk2low, and the multipotent progenitor popula-
tion LK+S+CD34+Flk2+, an increase in the frequency of all three
populations in the absence of Caspase-3 was noted. Most striking
was an3- to 4-fold increase in the immunophenotypic long-term
repopulatingHSC fraction (Figure1C). Incontrast, no increase was
observed in the frequency of the progenitor-containing population
(LK+S), nor was there evidence for an increase in the frequency of
colony-forming cells (CFC), an in vitro functional readout of pro-
genitor cells (FigureS3).Analysisofdifferent subpopulationswithin
the progenitor pool revealed similar frequencies of the granulo-
cyte-macrophage progenitors (GMP) and megakaryocyte-ery-
throid progenitors (MEP) between the genotypes, but a significant
decrease in the common myeloid progenitors (CMP) in KO mice
(Figure 1C). No differences in the frequency of common lymphoid
progenitors (CLP) between the genotypes were observed. These
data indicate a preferential expansion of primitive hematopoietic
populations with a concomitant reduction in early myeloid progen-
itors. Further quantitation of the number of stem cells by compet-
itive limit-dilution transplantation was not possible because we
defined abnormalities in the proliferation and differentiation of
primitive cells in the absence of Caspase-3 as described below.
These functional changes make the standard quantitation of
stemcells bymeasuring the contribution ofdonor cells to the blood
of recipients, uninterpretable.
Caspase-3 Deletion Minimally Affects Primitive
Hematopoietic Cell Apoptosis but Augments
Proliferation
Given that Caspase-3 is a known effector of apoptosis, we ques-
tioned if the observed differences in primitive subpopulations in
KO mice could be accounted for by altered susceptibility to ap-
optotic stimuli. Using the AnnexinV/DAPI assay, we analyzed
freshly isolated bone marrow cells for their expression of Annex-
inV and the exclusion of the nuclear dye DAPI. No significant dif-
ference in the frequency of AnnexinV+/DAPI– cells within the
stem and progenitor cell-containing populations was observed
(Figure 2A and Figure S4). The TUNEL assay, which detects ap-
optosis at the later DNA fragmentation stage, is not reliable in
vivo due to the elimination of dying cells by resident macro-586 Cell Stem Cell 2, 584–594, June 2008 ª2008 Elsevier Inc.phages. We used this assay in vitro to measure susceptibility
to apoptosis-inducing signals using cytokine starvation, gamma
irradiation, or heat shock (Williams et al., 1990; Domen et al.,
2000; Kadhim et al., 1995) of FACS-sorted LK+S+ cells; hemato-
poietic stem cells do not express the Fas receptor (Aguila and
Weissman, 1996; Bryder et al., 2001). With cytokine starvation
or gamma irradiation, we detected a reduction in the frequency
of apoptotic cells in the absence of Caspase-3 (Figure 2B and
Figure S5); however, no difference was observed after heat
shock treatment (data not shown). Given the lack of evidence
for increased apoptosis in vivo and the conflicting results of
the in vitro assays, we regarded apoptosis as being unlikely by
itself to account for the phenotypic changes observed in
Caspase-3 deficient mice.
We therefore analyzed whether Caspase-3 affects prolifera-
tion of primitive hematopoietic cells in vivo. Using a BrdU incor-
poration assay, we determined the frequency of LK+S+ cells that
have initiated at least one cell division within 24 hr of BrdU
administration. LK+S+ cells from Caspase-3–/– mice displayed
a significantly higher proliferation rate than their wild-type coun-
terparts (Figure 2C). The analysis of different stages of the cell
cycle within the LK+S+ population revealed a shift from G0
toward G1, ultimately resulting in a higher percentage of cells
that were in mitotic (S/G2/M) stages of the cell cycle
(Figure 2D). This increase by 4-fold in cells in G1 is dramatic
and of greater magnitude than that previously observed by us
and others in other genetic mutants affecting hematopoietic
stem cell cycling (Cheng et al., 2000; Hock et al., 2004; Janzen
et al., 2006). These data demonstrate that Caspase-3 limits cell
cycling in primitive hematopoietic cells.
The Effect of Caspase-3 Deletion on HSCs
Is Hematopoietic Cell Autonomous
Caspase-3 KO mice display growth retardation due to a delay in
bone formation (Miura et al., 2004). To examine whether micro-
environmental changes present in Caspase-3-deficient mice
are responsible for the phenotype within the stem cell compart-
ment, we transplanted KO and WT bone marrow cells into le-
thally irradiated WT recipients and monitored their peripheral
blood and bone marrow reconstitution. A congenic mouse sys-
tem was utilized such that donor cells all expressed the panhe-
matopoietic surface marker CD45.1 and were transplanted into
CD45.2 allele-bearing hosts (Figure 3A). Though we noted signif-
icant reductions in peripheral blood myeloid and lymphoid cells
at all time points examined (Figure 3B), a consistent increase in
the primitive LK+S+CD34low cell population was observed in
the bone marrow of WT recipients of a Caspase-3 null graft
(Figure 3C). In contrast, the progenitor-containing population
(LK+S) was reduced in recipients of mutant bone marrow, a phe-
notype reminiscent of the distribution of these populations ob-
served in KO bone marrow prior to transplantation. To further
exclude the effect of the Caspase-3–/– bone marrow microenvi-
ronment on adult hematopoiesis, we transplanted wild-type
bone marrow into lethally irradiated KO and littermate control
mice. Analysis of recipient peripheral blood revealed no differ-
ences in engraftment between the genotypes at all time points
examined (Figure 3D), indicating that a Caspase-3 deficient mi-
croenvironment does not impact the engraftment kinetics of
hematopoietic stem cells.
Cell Stem Cell
Caspase-3 Limits HSC Cytokine ResponseFigure 2. Caspase-3 Minimally Affected the Rate of Apoptosis but Increased Proliferation of LK+S+ Cells
(A) Analysis of the frequency of early apoptotic cells by the AnnexinV-DAPI assay on freshly isolated bone marrow LK+S+ cells. No difference in the frequency of
apoptotic events within the LK+S+ population was detectable between WT and Caspase-3 KO cells. FACS plots are gated on lineage-negative, cKit-positive, and
Sca-1-positive bone marrow cells, and numbers indicate the percentage of early apoptotic cells within the LK+S+ population. Values are mean ± SD, n = 8, p = NS.
(B) Sorted LK+S+ cells were expanded in vitro and cultured in presence of stem cell factor and thrombopoetin without specific apoptotic stimuli, or cell death was
induced by cytokine starvation or gamma irradiation. TUNEL analysis revealed a consistent reduction of TUNEL-positive cells in Caspase-3-deficient cells. Num-
bers indicate percentage of TUNEL-positive cells of an individual representative experiment. The experiment was repeated four times with similar results.
(C) Proliferation activity of LK+S+ cells was assessed using BrdU incorporation over 24 hr. Caspase-3-deficient cells displayed an elevated cycling activity com-
pared to WT littermate controls. Values are mean ± SD, n = 4, *p < 0.02.
(D) Analysis of the different cell cycle stages using Hoechst 33342 and PyroninY assay revealed significant reduction of Caspase-3/ LK+S+ cells in the quiescent
G0 stage of the cell cycle with a consecutive shift toward the G1 and the mitotic S/G2/M phases of the cell cycle. Values represent distributions of one repre-
sentative experiment. n = 4, *p < 0.001.Caspase-3 Deficiency Does Not Reduce the Serial
Transplantation Ability of HSCs but Affects Their
Differentiation
Several proteins involved in cell cycle control have been demon-
strated to be essential for the preservation of the repopulation abil-ity of hematopoietic stem cells (Cheng et al., 2000; Hock et al.,
2004; Janzen et al., 2006). To analyze whether Caspase-3 deletion
has an impact on the maintenance of the stem cell pool, we per-
formed sequential bone marrow transplantations (Figure 4A).
Though a consistently reduced number of mature blood cellsCell Stem Cell 2, 584–594, June 2008 ª2008 Elsevier Inc. 587
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Caspase-3 Limits HSC Cytokine ResponseFigure 3. Caspase-3 Deletion Causes a Cell-Autonomous Effect on HSC
(A) Schematic of the transplant and analysis setting. Test bone marrow from CD45.1-bearing WT or Caspase-3 KO bone marrow was transplanted into lethally
irradiated 45.2 recipients and monitored for peripheral blood and bone marrow reconstitution.
(B) Short- and long-term analysis of peripheral blood cells at 3 and 12 weeks posttransplant, recipients of mutant cells showed significantly fewer white blood
cells in all lineages compared to their WT counterpart. Values are mean ± SD, n = 8, *p < 0.002.
(C) Bone marrow analysis at 12 weeks posttransplant revealed an increase in the frequency of LT-HSC and a reduced frequency of progenitors in Caspase-3 KO
recipients compared to wild-type control bone marrow recipients. Values are mean ± SD, n = 3, *p < 0.05.
(D) Transplant of wild-type bone marrow into Caspase-3-deficient microenvironment revealed a negligible role of Caspase-3/ niche in affecting hematopoietic
stem cell homeostasis. Monitoring the repopulation kinetic of different hematopoietic cell lineages after transplantation into Capase-3-deficient mice or the WT
littermate controls displayed similar results in the short- and long-term engraftment. The presented graph shows peripheral blood counts 12 weeks after bone
marrow transplant. Values are mean ± SD, n = 4, p = NS.were detected in recipients of the Caspase-3/ bone marrow at
each round of the transplant, a significantly larger pool of mutant
LK+S+ cells was apparent even after the fourth serial transplant
(Figure 4B). These data are consistent with a preserved, cell-
autonomous, self-renewal ability of immunophenotypic hemato-
poietic stem cells in the absence of Caspase-3, despite the
observed elevation of proliferation rate within this population.
Next we sought to investigate the ability of KO HSCs to repo-
pulate irradiated hosts in the presence of competing wild-type
donor cells. Peripheral blood and bone marrow samples were
assayed 16 weeks following transplantation for the relative con-
tribution of donor cells to the blood and bone marrow based on
their expression of the CD45.1 or CD45.2 antigens (Figure 4C).
Though we observed comparable peripheral blood cell produc-
tion and distribution between the genotypes, a disproportionate
increase in mutant LK+S+ cells was observed, reflecting either588 Cell Stem Cell 2, 584–594, June 2008 ª2008 Elsevier Inc.the increase in stem cells present in the original graft or in-
creased reconstitution of the stem cell compartment by higher
proliferating Caspase-3/ cells (Figure 4D). Of note, the in-
crease in Caspase-3/-primitive cells was paired with a relative
reduction of more mature cells. In association with unaltered
apoptosis, these data are consistent with a negative impact on
the differentiation of immature cells with the loss of Caspase-3
expression.
Loss of Caspase-3 Perturbs Signaling via the Ras-Raf-
MEK-ERK Pathway in a Cell Type-Specific Manner
The analysis of peripheral blood cells from unmanipulated
Caspase-3/ mice revealed a striking reduction in mature B lym-
phocytes. The deficit of mature B cells in the absence of Cas-
pase-3 was exacerbated in the various transplant settings studied
(Figure S1 and Figures 3B and 4B). The regulatory role of
Cell Stem Cell
Caspase-3 Limits HSC Cytokine ResponseCaspase-3 on splenic B-cell proliferation has been established pre-
viously (Woo et al., 2003). However, the requirement for Caspase-3
in the differentiation of earlier B-cell subpopulations has not been
explored. Available markers can distinguish steps in early B-lineage
differentiation in a precise manner; we, therefore, analyzed KO bone
marrow for its composition of B-cell precursors. We observed a rel-
ative increase in the pro-B cell population, and a reduction in the
subsequentpre-Bpopulationof theB lineage (Figure5A),consistent
with a partial developmental block at this important transition. The
molecularprocesses responsible for thepro-Btopre-Bcell differen-
tiation step are well characterized and require intact signaling
through the interleukin-7 (IL-7) receptor activating the extracellular
signal-regulated kinase (ERK) signaling pathway (Fleming and
Paige, 2001; Milne et al., 2004). The Ras-Raf-MEK-ERK signaling
pathway controls fundamental cellular processes in a cascade of
phosphorylation events (O’Neill et al., 2004). Membrane-proximal
activation of Ras family members in turn phosphorylate Raf,
followed by the serine-threonine kinase MEK, which finally phos-
phorylates ERK1/2. Numerous receptors use this pathway, and it
is activated in hematopoietic precursors following stimulation with
Figure 4. Caspase-3 Deletion Preserves
Hematopoietic Stem Cell Pool but Perturbs
the Differentiation of Hematopoietic Cells
(A) Serial bone marrow transplantation assay was
performed to analyze the ability of Caspase-3 de-
ficient HSC to sustain the proliferative stress of re-
petitive transplantation rounds.
(B) Analysis of bone marrow subpopulations and
peripheral blood counts at each round of bone
marrow transplant revealed a preservation of the
LK+S+ cells but reduced number of peripheral
blood leukocytes even at the fourth round of trans-
plant. In contrast to the HSC-containing LK+S+
cells, the progenitor compartment (LK+S) did
not reflect the same accumulation of undifferenti-
ated mutant cells. The results of the recipients of
the fourth transplant at 16 weeks posttransplant
are shown. The experiment was performed twice
with similar results. Values are mean ± SD, n = 8,
*p < 0.001.
(C) Schematic presentation of the competitive re-
population assay, which was performed to test
the ability of mutant stem cells to compete against
wild-type HSC. At 16 weeks posttransplant, bone
marrow and peripheral blood cells were analyzed
for donor contribution.
(D) Though recipients of the control group express
an equivalent contribution of WT test and compet-
itor cells to the primitive and mature hematopoietic
progenies, Caspase-3/ LK+S+ cells outcom-
peted their wild-type counterparts. In contrast,
the more mature progenitor population did not re-
flect the same degree of excess as the stem cells
and were partially ousted by the competitor LK+S
cells. Finally, no difference between the genotypes
in the distribution of mature cells was found. The
experiment was repeated twice with similar re-
sults. Values are mean ± SD, n = 5, *p < 0.001.
Figure 5. Caspase-3 Deficiency Impairs
B-Cell Maturation by Affecting Signaling via
the Ras-Raf-MEK-ERK Signaling Pathway
(A) Analysis of B-cell development in presence or
absence of Caspase-3 revealed a reduction of
the pre-B cells fraction and a relative accumulation
of the pro-B cells fraction within the B-cell com-
partment, indicating an incomplete block at the
pro-B to pre-B transition in Caspase-3/ mice.
Values are mean ± SD, n = 5, *p < 0.05.
(B) Stimulation of WT and Caspase-3 KO pro-B
cell line with IL-7 revealed defective signaling
through the ERK-MAPK signaling pathway, while
the JAK-STAT pathway remained unperturbed in
the absence of Caspase-3. The experiment was
performed twice with similar results.Cell Stem Cell 2, 584–594, June 2008 ª2008 Elsevier Inc. 589
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Caspase-3 Limits HSC Cytokine Responsespecific cytokines (Uchida et al., 2001; Akbarzadeh et al., 2002).
Thus, we addressed whether Caspase-3 deficiency affects the IL-
7-mediated ERK signaling cascade. Using IL-7-dependent WT
and Caspase-3/ pro-B cell lines, we examined the kinetics of
ERK phosphorylation after stimulation with IL-7. Though we ob-
served phosphorylation of ERK1/2 in wild-type cells, no pERK
was detectable in Caspase-3 null cells (Figure 5B). However, a sim-
ilar effect was not noted in the JAK-STAT pathway, as levels of
pSTAT5 were unaffected by the absence of Caspase-3.
Cytokines known to alter stem cell behavior, including kit li-
gand, flt-2 ligand, IL-3, and TPO utilize receptors that activate
the Ras-Raf-MEK-ERK pathway (Jalal et al., 2004; Nonami
et al., 2004; Robinson et al., 1998; Rouyez et al., 1997). We there-
fore examined whether Caspase-3 modulates the intensity of
signal transduction within cells enriched for HSCs to account
for the differences in proliferation and differentiation in the
knockout animals. Bone marrow LK+S+ cells from WT and Cas-
pase-3 KO mice were isolated and subjected to cytokines with
recognized effects on hematopoietic stem cells, including kit li-
gand or stem cell factor (SCF), interleukin-3 (IL-3), thrombopoe-
tin (TPO), interleukin-6 (IL-6), stromal derived factor (SDF), and
angiopoietin-1 (Ang1). Specific cytokines demonstrated altered
activation of ERK in the setting of Caspase-3 deficiency.
Elevated phosphorylated ERK in Caspase-3-deficient LK+S+
cells compared with WT controls was noted at multiple time
points after stimulation by SCF or IL-3 (Figure 6A). The effects
on pERK levels were highly cytokine specific; however, TPO
resulted in a decrease in pERK levels in knockout LK+S+ cells
(Figure 6A), whereas IL-6, SDF, and Ang1 had no activating
effect on the ERK pathway (Figure 6B). These data indicate
that the effects of Caspase-3 are not common to all activators
of the ERK pathway. Therefore, Caspase-3 alters signaling
dependent upon both the cell type and the specific stimulus.
To determine the critical step at which the Caspase-3 affects
ERK signaling, we examined the activity of proteins upstream
of ERK. Analysis of MEK phosphorylation upon stimulation of
WT and Caspase-3/ BM cells with SCF revealed elevated
levels of activated MEK in Caspase-3 null cells compared with
wild-type controls (Figure 6C), indicating that the effect of Cas-
pase-3 was upstream of both ERK and MEK.
Next we assessed whether the differences noted were re-
stricted to the ERK pathway, or if Caspase-3 deletion affects sig-
naling across different pathways. We analyzed the activation of
p38MAPK with cytokines that did (SCF) or did not (IL-6) have al-
tered ERK phosphorylation in the KO LK+S+ cells. No changes in
p38MAPK phosphorylation were noted at multiple time points
(Figure S6). Similarly, when we examined pathways activated
with particular cytokines, such as AKT activation after SCF stim-
ulation or Stat3 activation after IL-6 or TPO signaling, we could
detect no effect of Caspase-3 deficiency (Figure 6D).
To further establish the mechanism by which Caspase-3
affects signal transduction, we asked whether Caspase-3 is ac-
tivated immediately following binding of a growth factor to its
corresponding receptor. Such a finding would suggest that Cas-
pase-3 is actively involved in signal transduction. We examined if
Caspase-3 cleavage was detectable in WT LK+S+ cells following
stimulation with cytokines. As shown in Figure S7, no cleaved
Caspase-3 was observed after stimulation of bone marrow cells
with SCF, despite apparent activation of ERK. To exclude the590 Cell Stem Cell 2, 584–594, June 2008 ª2008 Elsevier Inc.possibility that low levels of Caspase-3 activation occurred,
but were undetectable due to technical limitations, we used Cas-
pase-3 specific inhibitors to eliminate its enzymatic activity.
However, short-term treatment of WT bone marrow cells with
the Caspase-3 inhibitor z-DEVD.fmk or the pan-Caspase inhibi-
tor z-VAD.fmk did not prevent ERK activation in LK+S+ cells
(Figure S8) or IL-7-dependent pro-B cells (Figure S9). One could
also speculate that Caspase-3 activation during specific cellular
processes, as it was reported in other cells types (Carlile et al.,
2004; Fernando et al., 2005), may lead to a certain degree of pro-
tein turnover. In Caspase-deficient cells, the lack of this enzy-
matic activity may cause an accumulation of some mediators
of cell signaling. However, no differences in the expression levels
of some selected participants of different signaling pathways
were detectable at steady state (Figure S10). These data suggest
that Caspase-3 has an indirect effect on ERK signal transduc-
tion, rather than a direct, immediate effect mediated by its enzy-
matic activity.
Others have reported that TGF-b may alter growth factor re-
sponsiveness, so we analyzed effects of Caspase-3 on TGF-b re-
sponse. Using the recently described assay to visualize signal
activity in single cells by immunostaining (Yamazaki et al.,
2006; Ema et al., 2006), we demonstrated low endogenous
TGF-b signaling in primitive cells independent of the Caspase-
3 genotype (Figure S11). Additional stimulation with TGF-b in-
creased the phosphorylation of Smad2 and 3 with no significant
differences between wild-type and KO cells (Figures S11 and
S12). To test whether TGF-b treatment would affect the clonal
expansion of primitive hematopoietic cells, we sorted single
wild-type and Caspase-3/ LK+S+ cells and cultured them in
presence of different cytokine cocktails. No significant differ-
ences were noted in the effects of TGF-b between the wild-
type and knockout cells (Figure S13). Therefore, Caspase-3
seems to selectively affect the Ras-Raf-MEK-ERK pathway in
a cell type- and cytokine-specific manner. Limiting cell numbers
precludes further detailed analysis of the affected events.
DISCUSSION
The processes of cell cycle control, self-renewal, differentiation,
and apoptosis are closely intertwined in controlling stem cell fate
during development and in adult homeostasis. Here we demon-
strate that changes in expression of a central member of the
apoptosis machinery, the protease Caspase-3, have multiple ef-
fects on hematopoietic stem cell homeostasis. Mice engineered
to be deficient for Caspase-3 demonstrated a striking increase in
the abundance of the most immature hematopoietic cells by the
only measure feasible in this model— immunophenotype. How-
ever, the accumulation of primitive hematopoietic cells was most
likely not due to the changes in the rate of apoptosis, because we
did not observe a difference in the frequency of apoptotic events
in any subfraction of the primitive compartment. Although we
demonstrated a reduction in the susceptibility to forced induc-
tion of apoptosis in an in vitro assay, the physiological relevance
of these results remain unclear. We cannot definitely rule out that
differences in the frequency of apoptotic events occur in vivo
that may escape our detection yet still have a cumulative effect
on stem cell homeostasis. However, this is likely to only partly
explain the phenotype we observed in Caspase-3 mutant HSCs.
Cell Stem Cell
Caspase-3 Limits HSC Cytokine ResponseFigure 6. Caspase-3 Affects Signaling via the Ras-Raf-MEK-ERK Signaling Pathway in Primitive Hematopoietic Cells in a Cytokine-Specific
Manner
(A) Stimulation of primary bone marrow cells with either 1 ng/ml SCF or IL-3 revealed an augmented signal transduction, whereas stimulation with 4 ng/ml TPO
resulted in decreased signal intensity via the ERK-MAPK pathway in absence of Caspase-3. FACS plots demonstrated are representative from three independent
experiments and are gated on LK+S+ cells.
(B) Stimulation with 10 ng/ml IL-6, SDF, or Ang1 did not reveal measurable phosphorylation of ERK1/2 in LK+S+ cells.
(C) Differential activation of MEK upon stimulation with SCF in Caspase-3 KO LK+S+ cells indicate an alteration in ERK signaling upstream of MEK.
(D) No difference between the genotypes was observed in the kinetic of AKT or Stat3 phosphorylation using the same conditions as for ERK detection.Cell Stem Cell 2, 584–594, June 2008 ª2008 Elsevier Inc. 591
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Caspase-3 Limits HSC Cytokine ResponseThe increased magnitude of the HSC-containing compart-
ment was primarily associated with accelerated proliferation of
KO cells. Previously, we and others had shown that cytokine re-
ceptors were expressed on hematopoeitic stem cells and yet
these cells were known to be cytokine resistant. (Berardi et al.,
1995; Cheng et al., 1996; Ivanova et al., 2002; Kiel et al., 2005)
We had hypothesized and shown that this was associated with
increased levels of cyclin-dependent kinase inhibitors, and
when these molecules were deleted, stem cell cycling increased
(Yuan et al., 2004). However, the ability of cells to enter into cycle
with that change may not be reflective of why stem cells are rel-
atively cytokine resistant. The data presented here suggest an-
other possible mechanism: Caspase-3 limits their ability to signal
via specific pathways of activation.
Entry into cycle was not the only abnormality of the Caspase-3
null cells, and increased cycling does not necessarily increase
the stem cell pool. An accelerated proliferation of hematopoietic
stem cells due to deletion of PTEN, a negative regulator of the
PI3K-AKT signaling pathway, is associated with the depletion
of hematopoietic stem cell pool within weeks after PTEN dele-
tion (Yilmaz et al., 2006). However, increased proliferation in
Caspase-3 deficient cells was associated with a preserved
stem cell pool even under the stress conditions of transplanta-
tion. Our data suggest that Caspase-3 deficient cells exhibit
differentiation delay at specific stages of hematopoiesis and it
may be that this effect contributes to the increased primitive
cell population.
The molecular basis for the phenotype of Caspase-3 null cells
is at least in part due to an increased sensitivity of mutant
primitive cells to exogenous signals. We defined the Ras-Raf-
MEK-ERK pathway to be altered in at least two types of KO
hematopoietic cells, lymphocytes, and stem cells. The direction
of modulation was curiously opposite in the two cell types. This,
coupled with the data that Caspase-3 activity at the time of cell
stimulation is not critical for the altered signaling phenotype,
suggests that Caspase-3 exerts its effect indirectly. The indirect
effects are cell type and cytokine specific and appear not to
overlap with the AKT or JAK-STAT pathways and not to be due
to changes in TGF-b signaling as these were not different
between the genotypes.
Indirect effects of Caspase-3 on activating the Ras-Raf-MEK-
ERK cascade proteins may be due to multiple actions. Accumu-
lation of a number of different Caspase-3 target proteins is most
likely and may still occur, despite the lack of short-term effects
by the enzymatic inhibitors. In mesenchymal stem cells, Miura
et al. noted increased Smad-2 in the absence of Caspase-3
(Miura et al., 2004). It is tempting to speculate that known targets
of Caspase-3, such as Raf-1 (Widmann et al., 1998), may be the
basis for the altered cytokine responsiveness we observed, but
this is one of many possibilities, and broadly examining protein
modifications in a stem cell population is not currently feasible.
Our data from the IL-7 stimulation in B-cell progenitors suggest
that the signaling alterations are highly cell-type specific. Given
the cell context dependence and multiple known targets of Cas-
pase-3, it is not our contention that the Ras-Raf-MEK-ERK path-
way is the only mechanism for the Caspase-3 effects. Rather, we
posit that this pathway is a contributor to altered cytokine sensi-
tivity and that cytokine response can account for some, if not all,
of the functional changes observed.592 Cell Stem Cell 2, 584–594, June 2008 ª2008 Elsevier Inc.In summary, the data presented here indicate that Caspase-3
is involved in cytokine-mediated signaling by different receptors
in primitive hematopoietic cells. Caspase-3 alters signal trans-
duction by limiting activation of the Ras-Raf-MEK-ERK pathway.
We postulate that Caspase-3 prevents the accumulation of acti-
vated components of the pathway and thereby restricts cytokine
response, serving as a molecular regulator of the known qui-
escence and cytokine resistance of hematopoietic stem cells.
As such, it is a mediator of stem cell homeostasis, evident in
the alteration of function of the stem cell compartment in its ab-
sence. Alteration of Caspase-3 levels either pharmacologically
or genetically may change the size and activity of the stem cell
compartment by means not reflected in vivo by measures of ap-
optosis. We therefore conclude that Caspase-3 modulates stem
cell responsiveness to the cytokine cues of the stem cell micro-
environment, selectively dampening specific signaling pathways
to maintain stem cell quiescence.
EXPERIMENTAL PROCEDURES
Mice
C57Bl/6 wild-type and Caspase-3 mice were bred in-house in a pathogen-free
environment. The Caspase-3 KO mouse was generated as previously de-
scribed (Woo et al., 1998) and backcrossed to C57Bl/6 for more than eight
generations. The Subcommittee on Research Animal Care of the Massachu-
setts General Hospital approved all animal work according to federal and insti-
tutional policies and regulations.
Cells and Cell Culture
WT and Caspase-3/ IL-7-dependent pro-B cell lines were generated and
maintained as described previously (Fleming and Paige, 2001). Bone marrow
was harvested as previously described (Cheng et al., 2000) and cultured in
CFU-C assays according to the manufacturers’ protocols (StemCell Technol-
ogies, Canada). Sorted L-K+S+ cells were cultured in HSC medium: X-Vivo 15
(Cambrex) supplemented with 10% detoxified BSA (StemCell Technologies),
50 U/ml penicillin (BioWhittaker), 50 U/ml streptomycin (Cellgro), 2 mM L-glu-
tamine (BioWhittaker), and 0.1 mM 2-mercaptoethanol (Sigma-Aldrich). Prior
apoptosis induction LK+S+ cells were cultured in presence of 50 ng/ml rmSCF,
50 ng/ml rmTPO, 50 ng/ml rmFlt-3L (all from PeproTech), and 20 ng/ml rmIL3
(R & D Systems). Forty-eight hours after initial stimulation, cells were main-
tained in culture in presence of 10 ng/ml rmSCF and 10 ng/ml rmTPO. After
total culture time of 96 hr, cells were washed with sterile PBS and subject to
apoptosis induction. Cytokine withdrawal assay was performed by washing
cells twice with PBS and placing in HSC medium with antibiotics and BSA
but without cytokines. Detection of apoptotic events was performed 48 hr
and 72 hr post-cytokine withdrawal with AnnexinV-DAPI and TUNEL respec-
tively. Mitogenic stimulation assay was performed by continuously culturing
of LK+S+ cells in HSC medium in presence of 10 ng/ml rmSCF and 10 ng/ml
rmTPO. Detection of apoptotic events was performed 4 and 5 days after be-
ginning of cell culture with AnnexinV-DAPI and TUNEL assays respectively. In-
duction of apoptosis by DNA damage was performed by gamma irradiation
with 2 Gy and additional culturing of cells in HSC medium in presence of
10 ng/ml rmSCF and 10 ng/ml rmTPO. Detection of apoptotic events was
performed 24 and 48 hr after irradiation with AnnexinV-DAPI and TUNEL assay
respectively. Heat-shock treatment was performed by incubation of the cells
for 60 min at 42C and subsequently culturing in HSC medium in presence
of 10 ng/ml rmSCF and 10 ng/ml rmTPO prior to detection of apoptosis 24
and 48 hr after heat-shock treatment with AnnexinV-DAPI and TUNEL assay
respectively. Clonal analysis were performed by sorting single LK+S+ cells in
96 well plates in HSC medium supplemented with 50 ng/ml SCF, 50 ng/ml
TPO, and 50 ng/ml Flt3-ligand, or with 50 ng/ml SCF, 50 ng/ml IL-6 (Pepro-
Tech), and 10 ng/ml IL-3; where indicated, 5 ng/ml TGF-b (R & D Systems)
was added. Colonies were scored at day 5 and day 11 for the presence of pro-
liferating clones by light microscopy.
Cell Stem Cell
Caspase-3 Limits HSC Cytokine ResponseFlow Cytometric Analysis and Sorting of Subpopulations
Lineage staining used a cocktail of biotinylated antimouse antibodies to Mac-
1a (CD11b), Gr-1(Ly-6G and Ly-6C), Ter119 (Ly-76), CD33, CD4, CD8a (Ly-2),
and B220 (CD45R; BD Biosciences). For detection and sorting we used strep-
tavidin conjugated with PE/Cy7, c-Kit-APC (CD117), Flk2-PE (CD135), CD34-
FITC (all from BD Biosciences), and Sca1-PE/Cy5.5 (Ly 6A/E; Caltag Labora-
tories). For congenic strain discrimination, anti-CD45.1-PE and anti-CD45.2
FITC antibodies (BD Biosciences) were used. To assess the cell cycle in the
primitive population, BM cells were stained with lineage antibodies and c-Kit
as above, anti-Sca-1 PE-Cy-7 (BD Biosciences), Pyronin Y (RNA dye), and
Hoechst 33342 (DNA dye) as described (Cheng et al., 2000). For BrdU incor-
poration we used the APC-BrdU Flow Kit (BD Biosciences) following a single
intraperitoneal injection of BrdU (1 mg per 6 g of body weight) and an additional
administration of 1 mg/ml of BrdU (Sigma) mixed to drinking water for approx-
imately 24 hr. Surface staining for lineage markers was performed as above,
Sca1-PE/Cy5.5, c-Kit-APC/Cy7 (eBioscience), and CD34-FITC. For the apo-
ptosis assay we used DAPI (Molecular Probes) and AnnexinV-APC (BD Biosci-
ences). To assess late stages of apoptosis, the APO-BrdU TUNEL Assay Kit
from Molecular Probes was used according to the manufacturer’s protocol.
For the intracellular detection of Caspase-3, cleaved Caspase-3 (both from
Cell Signaling Technology) bone marrow cells were fixed and permeabilized
using BD Cytofix/Cytoperm Fixation/Permeabilization Solution Kit (BD Biosci-
ences) according to the manufacturer’s recommendations.
Cell Stimulation and Detection of Protein Phosphorylation
Prior to stimulation, pro-B cells were washed in OptiMEM + 0.5% FCS to re-
move IL-7 and starved for 4–6 hr in a 37C humidified incubator at 5 3 106
cells/ml. Cells were resuspended at 107 cells/ml at 37C and stimulated by
the addition 10–25 ng/ml murine IL-7 for the times indicated. Cells were lysed
at 53 107 cells/ml in 1% NP40, 150 mM NaCl, 20 mM Tris-HCl (pH 7.4), 1 mM
EDTA, 10 mM sodium fluoride, 1 mM sodium orthovanadate, 5 mM sodium
pyrophosphate, 1 mM PMSF, and 5 mg/ml aprotinin and leupeptin (Boehringer
Mannheim) on ice for 20 min. The detergent-insoluble fraction was removed by
centrifugation. Protein samples (equivalent of 6 3 105–1.2 3 106 cells) were
mixed with 43 NuPAGE sample buffer (Invitrogen) and 0.7 M 2-ME, resolved
on a gradient NuPAGE gel and transferred to a PVDF membrane in 20 mM
Tris, 150 mM glycine, 20% methanol. Detection of phosphorylated ERK1/2
and STAT5 was performed according to the manufacturer’s instructions
(NEB). For loading controls, membranes were stripped in 6.25 mM TRIS
(pH 6.8), 2% SDS, and 100 mM 2-ME (50C, 25 min), washed in TBST, and re-
probed with actin as above. Bone marrow cells were harvested and precul-
tured in HSC medium (see above) without cytokines for 1–2 hr and stimulated
with the implied cytokines for the time indicated. Subsequently, the cells were
fixed and permeabilized using Phosflow Lyse/Fix and Perm/Wash buffers
(both from BD Biosciences) according to manufacturer’s instructions. Cells
were then stained for surface markers to define the HSC-containing population
as described above and with antibodies against pERK1/2, p-p38 (both from
BD Biosciences), pAKT, pMEK1/2, pStat3, pSmad-2, pSmad-3, or active
(cleaved) Caspase-3 (all from Cell Signaling). Proteolytic inhibition of Cas-
pase-3 activity was performed by incubation of bone marrow cells with the ir-
reversible Caspase-3 selective inhibitor z.DEVD.fmk or the general Caspase
inhibitor z.VAD.fmk (both from BD Biosciences) at a concentration of 20 mM
for 60 min prior to stimulation with cytokines. Single-cell immunostaining
was performed according to the protocol described by Ema et al. (2006).
Transplantation Assays
For serial transplantation, 2 3 106 whole bone-marrow cells from 8- to
12-week-old WT and Caspase-3 KO (CD45.2) littermates were injected into
lethally irradiated (9,5 Gy) female recipient Bl6-SJL (CD45.1) mice. Engraft-
ment efficiency in recipients has been monitored by donor contribution of
CD45.2-positive cells using FACS analysis. Peripheral blood cell counts
were obtained by tail vein nicking 3, 8, and 16 weeks posttransplantation. Eight
weeks posttransplantation, recipients were used as donors for the next trans-
plantation cycle and for assessment for the contribution of donor-derived
primitive BM subpopulations. Transplants were discontinued after the fourth
round of transplantation. For the competitive repopulation assay with bone
marrow from young mice we used 5 3 105 WT or Caspase-3 KO whole
bone-marrow cells from CD45.2 littermates (8 weeks old) mixed with 5 3 105CD45.1 (competitor) WT cells and injected into lethally irradiated CD45.1
recipient mice. Repopulation was assessed by flow cytometry at 16 weeks
posttransplant for multilineage reconstitution.
PCR and Gene Expression Analyses
Caspase-3 genotyping was done as described previously (Woo et al., 1998).
RNA was isolated from FACS sorted bone marrow subpopulations using the
PicoPure Kit (Arcturus Bioscience). Predesigned assays for Caspase-3 and
Hprt-1 were purchased from Applied Biosystems (assay IDs Mm01195082
and Mm00446968, respectively).
Statistical Analysis
The Student’s t test was used to determine the significance of the difference
between the means; significance was set at p values less than 0.05.
SUPPLEMENTAL DATA
Supplemental Data include 13 figures and can be found with this article online
at http://www.cellstemcell.com/cgi/content/full/2/6/584/DC1/.
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